It has been reported to be overexpressed in colorectal cancer, and the reported benefit of using aspirin to reduce the risk of colorectal cancer is almost exclusively limited to COX-2-positive colorectal cancer (41). This evidence concerns the gene PTGS2 and colorectal cancer.